|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/64 | |
| A61K 31/44 | |||
| A61K 31/40 | |||
| A61K 31/549 | |||
| A61K 31/00 | |||
| A61P 25/00 | |||
| A61P 35/00 | |||
| A61K 31/565 |
| (11) | Number of the document | 1799227 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05812199.7 |
| Date of filing the European patent application | 2005-09-16 | |
| (97) | Date of publication of the European application | 2007-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2010-11-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/033194 |
| Date | 2005-09-16 |
| (87) | Number | WO 2006/034048 |
| Date | 2006-03-30 |
| (30) | Number | Date | Country code |
| 610758 P | 2004-09-18 | US | |
| 698272 P | 2005-07-11 | US |
| (72) |
SIMARD, Marc, J., US
|
| (73) |
University of Maryland, Baltimore,
515 West Lombard Street, 5th Floor, Baltimore, MD 21201-1602,
US
Department of Veterans Affairs, Office of the General Counsel-PSG IV (024), 810 Vermont Avenue NW, Washington, DC 20420, US |
| (54) | THERAPEUTIC AGENTS TARGETING THE NC CA-ATP CHANNEL AND METHODS OF USE THEREOF |
| THERAPEUTIC AGENTS TARGETING THE NC CA-ATP CHANNEL AND METHODS OF USE THEREOF |